Neuropharmacology 2019, 153: 112
Facial Volume Loss From GLP-1s GLP-1 medications, such as Ozempic, Wegovy and Mounjaro, have helped many people lose significant weight, but not without side effects
GLP-1 medications do not directly cause vitamin deficiencies in everyone, but they can make them more likely over time by lowering appetite and reducing overall food intake
Over the next decade, several longer-acting versions were developed, including: Victoza (liraglutide) approved in 2010 Bydureon approved in 2012 Trulicity approved in 2014 During this period the medications were primarily prescribed for diabetes , and awareness outside medical circles was relatively limited
Am J Health Syst Pharm
A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia